Navigation Links
Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion
Date:12/6/2008

SAN FRANCISCO, Dec. 6 /PRNewswire/ -- Researchers today report that after the implementation of Medicare coverage limitations for erythropoiesis-stimulating agents (ESAs), a significantly greater proportion of anemic cancer patients who were on chemotherapy and who received ESAs needed blood transfusions and utilized more units of blood per patient than those patients who received ESAs prior to implementation of coverage limitations. The findings from this observational study will be presented at the 50th Annual Meeting of the American Society of Hematology on Saturday, December 6th at 9:00 a.m. PST.

In July 2007, the Centers for Medicare and Medicaid Services (CMS) issued coverage limitations, in the form of a National Coverage Determination (NCD), for the use of ESAs in anemic cancer patients receiving chemotherapy. An ongoing, prospective, observational study [Dosing and Outcomes Study of Erythropoiesis-Stimulating Therapies (DOSE) registry] is evaluating ESA-treated anemic cancer patients receiving chemotherapy. The present analyses were conducted using data from this study, focused on patients covered by Medicare before and after implementation of the CMS NCD for ESAs.

"We wanted to examine the potential impacts on transfusion patterns and hematologic changes in anemic Medicare patients receiving chemotherapy treated with ESAs before and after implementation of the ESA coverage limitations," said study director Chris L. Pashos, PhD, Vice President, Abt Bio-Pharma Solutions, Inc. "Our analyses found increased transfusion rates and greater blood utilization in anemic Medicare patients receiving chemotherapy and treated with ESAs after implementation of the ESA NCD compared with before implementation of the ESA NCD."

Study Methods and Results

Data from 288 Medicare patients (pre-NCD: 230, post-NCD: 58) from 41 sites included in the DOSE registry were analyzed. Data we
'/>"/>

SOURCE Ortho Biotech Products, L.P.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions
2. Observational Data Show Transfusion Patterns in Chemotherapy-Induced Anemia Patients Receiving Erythropoiesis-Stimulating Agents
3. GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP
4. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
5. RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China
6. Gene Therapy Corrects Sickle Cell Disease in Laboratory Study
7. Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study
8. Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful
9. PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S.
10. Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention
11. PreMD Inc. Enters Clinical Study with Cosmetics Conglomerate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 3SBio Inc. (NASDAQ: ... China -based biotechnology company focused ... announced today that, at an extraordinary general meeting ... in favor of the proposal to authorize and ... merger dated February 8, 2013, among Decade Sunshine ...
(Date:5/23/2013)... SAN DIEGO , May 23, 2013 Neurocrine ... Kevin Gorman , President and Chief Executive ... Bank 38 th Annual dbAccess Health Care Conference in ... Thursday, May 30 at 11:20 a.m. Eastern Time / 8:20 ... be accessed on the Company,s website at http://www.neurocrine.com . ...
(Date:5/23/2013)... May 23, 2013 Nephros, Inc. (OTC Bulletin ... device company that develops and sells high performance liquid ... rights offering.  In addition, the concurrent temporary reduction in ... on May 17, 2013. Nephros estimates that ... the rights offering.   A portion of the proceeds will ...
Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
... , CONCORD, Calif. , Feb. 3 Pulse Systems ... the Western United States . Effective February 1, 2010 , Diverse ... exclusive sales territory encompassing the states of California (except for the ... Oregon , Washington , Colorado , Utah , Idaho ...
... , VIENNA, Va. , Feb. 3 ... , Chief Executive Officer, will be presenting at the 2010 BIO ... the conference will take place February 8-9 at the ... be on Tuesday, February 9th , at 1:30 p.m. ...
Cached Medicine Technology:Pulse Systems Announces New Sales Representation in the Western United States 2Pulse Systems Announces New Sales Representation in the Western United States 3CEL-SCI to Present at 12th Annual BIO CEO & Investor Conference 2
(Date:5/24/2013)... According to the new market research report “Micro Irrigation ... published by MarketsandMarkets, global micro irrigation system market expected ... year 2010 and is expected to reach $3,414.7 million ... 2011 to 2016. , Browse:, , ... , 370 pages and in-depth Table Of ...
(Date:5/24/2013)... Pittsburgh, PA (PRWEB) May 24, 2013 ... may be more likely to suffer from gastroesophageal reflux ... physicians reported in a study published today. , ... and Abnormal Proximal Exposure as Measured by Hypopharyngeal Multichannel ... “These findings could be of great importance to individuals ...
(Date:5/24/2013)... 24, 2013 For the second consecutive ... Fresh Express Café to treat Tabitha Meals on Wheels ... their door. More than 400 meal recipients recently enjoyed ... restaurants, along with the rest of a well-balanced, nutritious ... to partner with the Tabitha Meals on Wheels team,” ...
(Date:5/24/2013)... May 24, 2013 With today’s levels of ... hunting for advice on the causes of weight gain and ... developed that suggest causes of weight gain and treatments that ... study was released by the Child Study Center at ... the childhood diagnosis of ADHD and the soring rates of ...
(Date:5/24/2013)... Today marks the launch of Destination Halifax’s latest ... The redesigned and enhanced Itinerary Builder will help visitors ... computer or mobile device that they can send, save, ... to fill in their date of arrival and length ... of vacation packages, accommodations, restaurants, and things to do ...
Breaking Medicine News(10 mins):Health News:Micro Irrigation System Market to Reach $3414.7 Million by 2016 at a CAGR of 17.9% - New Report by MarketsandMarkets 2Health News:Micro Irrigation System Market to Reach $3414.7 Million by 2016 at a CAGR of 17.9% - New Report by MarketsandMarkets 3Health News:West Penn Allegheny Health System Physicians Pinpoint Gastroesophageal Reflux Disease (GERD) as a Factor That May Cause Chronic Cough 2Health News:Runza® Delivers Sandwiches, Draws Smiles from Tabitha Meals on Wheels Clients 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Now Help Patients with Weight Gain Linked to Childhood ADHD Lose Weight Fast 2Health News:Create and Win the Perfect Halifax Getaway with the All-New Itinerary Builder 2
... Steve TyrellSpecial Performance by Dancing With The Stars ... actress Bonnie Hunt will receive the "True ... Harvey Rosen will receive "The Duke" ... 24th annual Odyssey Ball. The yearly fundraising ...
... added section on hospital care and advice on drugs ... News) -- New guidelines for treatment of heart failure ... the American College of Cardiology, with a strong emphasis ... also on the treatment of blacks. , "The most ...
... Survey conducted by the Society of Corporate Compliance and ... In the face of reports on AIG bonuses it ... of the gifts employees can give and receive and ... a survey the Society of Corporate Compliance and Ethics ...
... Possis Acquisition and Patient Care Innovations WARRENDALE, Pa., ... over $600 million in 2008, an increase of ... (excluding the effect of the Possis Medical, Inc. ... and therapeutic medical devices, MEDRAD has achieved a ...
... Software Upgrade Enhances Company,s Lead in Data Quality, ... AnalysisPITTSBURGH, March 26 Neuro Kinetics, Inc. (NKI) ... evaluation equipment used worldwide for balance, vestibular and ... release version 6.7 of its proprietary VEST(TM) control ...
... (NYSE Amex: DPW ) today announced its financial ... December 31, 2008.Digital Power reported net income of $142,000 for ... income of $235,000 for the three months ended December 31, ... 2008, compared to operating income of $206,000 for the fourth ...
Cached Medicine News:Health News:John Wayne Cancer Institute Auxiliary Honors Award-Winning Actress Bonnie Hunt and Philanthropists Donna & Harvey Rosen at the 24th Annual Odyssey Ball 2Health News:New Guidelines for Treating Heart Failure 2Health News:New Guidelines for Treating Heart Failure 3Health News:Bonuses May be Big but Don't Expect a Lavish Dinner or Gift 2Health News:MEDRAD(R) Revenues Grow 10 Percent in 2008 2Health News:MEDRAD(R) Revenues Grow 10 Percent in 2008 3Health News:MEDRAD(R) Revenues Grow 10 Percent in 2008 4Health News:Neuro Kinetics to Release VEST(TM) 6.7 Software at Audiology Conference 2Health News:Neuro Kinetics to Release VEST(TM) 6.7 Software at Audiology Conference 3Health News:Digital Power Reports Financial Results for the Fourth Quarter and the Year Ended December 31, 2008 2Health News:Digital Power Reports Financial Results for the Fourth Quarter and the Year Ended December 31, 2008 3Health News:Digital Power Reports Financial Results for the Fourth Quarter and the Year Ended December 31, 2008 4
... Used for stone manipulation and ... Enhanced wire strength permits the ... more readily than standard flat-wire ... easy, ergonomic one-handed operation. Supplied ...
... manipulation and removal in the urinary tract. The ... its shape following extreme torsion. The unique tipless ... the basket to open at the base of ... design reduces the likelihood of mucosal damage and ...
Used to establish and maintain nephrostomy drainage following pyeloplasty. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is advised; stent must not r...
... Analyzer is an in vitro diagnostic ... chemistry parameters using Reflotron Test Tabs. It works ... rapid and reliable results while being easy to ... display and the profile can be printed out ...
Medicine Products: